{"SPADE_UN_19184": {"Sequence Information": {"Peptide Name": "FR-15", "Sequence": "FRRFFKWFRRFFKFF", "Sequence Length": 15, "Biological Activity": ["Anti-Gram+", "Anti-Gram-", "Anticancer", "Antifungal", "Anti-Mammalian Cell"], "Binding Target": "1. Lipid Bilayer", "Source": "", "Gene": "", "PDB ID": "", "UniProt Entry": [], "Literature": [{"Title": "Selective phenylalanine to proline substitution for improved antimicrobial and anticancer activities of peptides designed on phenylalanine heptad repeat.", "Pubmed ID": "28483698", "Reference": "Acta Biomater. 2017;57:170-186", "Author": "Tripathi AK, Kumari T, Tandon A, Sayeed M, Afshan T, Kathuria M, Shukla PK, Mitra K, Ghosh JK", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/28483698"}], "Mass": 2262.7, "PI": 12.0, "Net Charge": 6, "Hydrophobicity": -0.29, "Frequent Amino Acids": "FRK", "Absent Amino Acids": "ACDEGHILMNOPQSTUVY", "Basic Residues": 6, "Acidic Residues": 0, "Hydrophobic Residues": 8, "Polar Residues": 7, "Positive Residues": 6, "Negative Residues": 0, "SPADE ID": "SPADE_UN_19184", "Similar Sequences": [{"SPADE_ID": "SPADE_N_12314", "Similarity": 1.0, "Sequence": "WFRR"}, {"SPADE_ID": "SPADE_UN_04218", "Similarity": 1.0, "Sequence": "RRFWFRR"}, {"SPADE_ID": "SPADE_UN_19184", "Similarity": 1.0, "Sequence": "FRRFFKWFRRFFKFF"}], "Hemolytic Activity": "Human erythrocytes:100% Hemolysis=70 µM", "Target Organism": "Escherichia coli ATCC 9637(MIC=7µM),Escherichia coli ATCC 25922(MIC=6.5µM),Escherichia coli ATCC 25922(MIC=10µM),Escherichia coli ATCC 25922(MIC=11.3µM),Escherichia coli ATCC 25922(MIC=45µM),Escherichia coli ATCC 25922(MIC=5.5µM),Escherichia coli ATCC 25922(MIC=26.5µM),Pseudomonas aeruginosa ATCC BAA-427(MIC=15.3µM),Klebsiella pneumoniae ATCC 27736(MIC=7µM),Bacillus subtilis ATCC 6633(MIC=3.8µM),Staphylococcus aureus ATCC 25923(MIC=14µM),Staphylococcus aureus ATCC 700698(MIC=>35µM),Staphylococcus aureus ATCC 700699(MIC=35µM),Staphylococcus aureus ATCC BAA-44(MIC=35µM),Staphylococcus aureus ATCC 29213(MIC=>35µM),Staphylococcus aureus ATCC 33592(MIC=>35µM),Candida albicans ATCC 10231(MIC=2.1µM),Cryptococcus neoformans(MIC=2.1µM),Candida parapsilosis ATCC 22019(MIC=1µM),Sporothrix schenckii(MIC=2.1µM),Trichophyton mentagrophytes(MIC=4.4µM),Aspergillus fumigatus(MIC=2.1µM),Human breast adenocarcinoma MDA-MB-231(IC50=3.15µM),Human cervical carcinoma HeLa(IC50=4.9µM),Human colon adenocarcinoma DLD-1(IC50=6.7µM),Human hepatocellular carcinoma HepG2(IC50=2.5µM)"}}}